TARA news

Latest 1 stories · newest Nov 6, 2026

TARA

Protara 3Q financials and updates TARA-002 manufacturing

Protara reported $143M cash and highlighted milestone progress for its TARA-002 treatments in NMIBC and lymphatic malformations, including the in-house acquisition of manufacturing assets.

Earnings Nov 6, 2026 sentiment +0.40 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same TARA feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/TARA/newsSTART FREE